Position in ANIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$166,244
+$8,418 QoQ
Shares Held
59,373
-2.9% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 62 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ANIX ranks #262 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ANIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $166,244 | 59,373 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $157,826 | 61,173 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $168,083 | 53,873 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $141,121 | 42,764 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $91,320 | 27,673 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $61,412 | 21,473 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $33,809 | 14,573 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $33,619 | 10,673 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $214,656 | 68,800 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $32,700 | 10,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $189,760 | 59,300 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $91,598 | 21,302 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $203,575 | 47,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $281,424 | 57,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $262,798 | 85,882 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $615,554 | 224,655 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $982,476 | 330,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,012,194 | 212,200 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $483,056 | 124,499 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $51,223 | 32,216 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||